Follow us
EN
EN

One of the main goals of Life4me+ — is to prevent new cases of HIV and other STIs, hepatitis C and tuberculosis.

The app helps to establish anonym communication between physicians and HIV-positive people. It allows you to conveniently organize your medication intake timetable and set concealed and personalized reminders.

All news

Archive

✕
18 January 2017
6361
Statins and vitamin D deficiency may cause muscle damage in people with HIV

Statins and vitamin D deficiency may cause muscle damage in people with HIV

Statins are medications which are prescribed to reduce the risk of cardiovascular disease by reducing cholesterol levels. Specifically, LDL cholesterol is responsible for the development of cardiovascular disease.
17 January 2017
5901
HIV neutralizing antibodies show promise

HIV neutralizing antibodies show promise

A collaborative team of German and American scientists published results of successful test of the HIV neutralizing antibody 10-1074. This new generation of highly potent antibodies is able to neutralize a number of HIV strains.
17 January 2017
7075
Zimbabwe: Major step in a fight against HIV

Zimbabwe: Major step in a fight against HIV

After adopting World Health Organisation (WHO) guidelines on HIV treatment and prevention, Zimbabwe will soon start pre-exposure prophylaxis (PrEP) programs in selected districts in the country. The programs will include people who do not have HIV but at risk of acquiring ...
16 January 2017
6864
Tribunal in Kenya rules in favor of victims of HIV stigma

Tribunal in Kenya rules in favor of victims of HIV stigma

The HIV and Aids Tribunal (HAT) in Kenya, responsible for hearing HIV discrimination cases and illegal disclosure cases, has awarded millions of shillings to HIV-positive individuals. Since 2012 there have been 348 cases claiming unlawful treatment of people living with ...
16 January 2017
6305
Study: High match between self-reported viral load and clinic-recorded viral load in PLWH in Great Britain

Study: High match between self-reported viral load and clinic-recorded viral load in PLWH in Great Britain

According to a study published in HIV Medicine there is a high accuracy of a self-report of undetectable VL among people receiving ART in the UK. The study took place in the United Kingdom and involved 2678 people receiving antiretroviral treatment. Over two-thirds (68%) ...
16 January 2017
8078
Charlie Sheen opens up about his life with HIV

Charlie Sheen opens up about his life with HIV

In his emotional new interview more than a year after he went public about his HIV status, famous actor spoke about his life. Charlie revealed that he was HIV positive in November 2015, four years after he was diagnosed.
13 January 2017
6988
EU approves hepatitis B therapy Vemlidy

EU approves hepatitis B therapy Vemlidy

Gilead Sciences, Inc. on January 11 announced that the European Commission has granted marketing authorization for Vemlidy (tenofovir alafenamide, TAF) 25 mg, a once-daily tablet for the treatment of chronic hepatitis B virus (HBV) infection in adults and adolescents (aged ...
12 January 2017
5680
Development of a new HIV-prevention drug implant will start soon

Development of a new HIV-prevention drug implant will start soon

Currently PrEP drugs are available only in the form of a pill that, if taken daily, can dramatically reduce a chance of being infected with HIV. But this can soon change. But this can soon change. Massachusetts-based pharmaceutical company Intarcia Therapeutics, is moving ...
12 January 2017
5906
London: Dramatic drop in number of new HIV infections

London: Dramatic drop in number of new HIV infections

After the adoption of a new early-intervention treatment program imported from San-Francisco, several major sexual health clinics in London reported an almost 50% fall in the number of new HIV infections.
11 January 2017
5683
The Gates Foundation to fund $9m to a firm working on HIV cure

The Gates Foundation to fund $9m to a firm working on HIV cure

The Gates Foundation of Bill and Melinda Gates awarded $9m to Kymab, Cambridge life sciences firm, to support its research and development of new vaccines and infectious disease prevention therapies. Kymab has been working with the Gates Foundation and its partners since ...
We use cookies on this site to enhance your experience.
By clicking any button on this website you are giving your consent for us to set cookies.